DETERMINATION OF CANCER PREDISPOSITION

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20130210124A1
SERIAL NO

13763449

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are systems and methods for using demethylation of genomic DNA for diagnosing, predicting, and/or monitoring the status or outcome of a neoplasm or a cancer in a subject.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE10901 NORTH TORREY PINES ROAD LA JOLLA CA 92037
INSTITUCIO CATALANA DE RECERCA I ESTUDIS AVANCATS (ICREA)PASSEIG LLUÍS COMPANYS 23 BARCELONA 08010
INSTITUT DE MEDICINA PREDICTIVA I PERSONALITZADA DEL CANCER (IMPPC)CARRETERA DE CAN RUTI CAMI DE LOS ESCOLES S/N BADALONA BARCELONA 08916

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ALONSO, Sergio Tiana, ES 1 0
PERUCHO, Manuel San Diego, US 5 39
SUZUKI, Koichi Omiya, JP 385 3803

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation